Drug Database
Back to search

Netherlands· NL-53ded1b1dab5

Steglatro 5 mg filmomhulde tabletten

A ertugliflozin product containing ertugliflozine-l-pyroglutaminezuur, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A10BK04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSteglatro 5 mg filmomhulde tablettenATCA10BK04REGISTER NO.NL-53ded1b1dab5PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ertugliflozine-l-pyroglutaminezuurAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ertugliflozin is registered in 11 of 19 countries.

Countries holding a registration under ATC A10BK04 (ertugliflozin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search ertugliflozin products by name

Ertugliflozin · ATC A10BK04

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ertugliflozin costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $2.89 in Italy to $4.50 in Switzerland — a ×1.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ertugliflozin · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.50
  • IT Italy$2.89
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ERTUGLIFLOZINE-L-PYROGLUTAMINEZUUR
Manufacturer
Merck Sharp & Dohme B.V.
Country
Netherlands (NL)
ATC code
A10BK04
ATC class
Ertugliflozin
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/18/1267

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

417 interactions on record for ertugliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ertugliflozin against other medicinesHow interaction checks work

Ertugliflozin · interactions on record

417 records

  • 1 severe
  • 376 moderate
  • 40 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • PapaverineA03AD01moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A10BK04

Ertugliflozin, as other registers publish it.

All ertugliflozin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/812fcfcc-310f-4e33-8395-985bb827973f
GET /v1/drugs/812fcfcc-310f-4e33-8395-985bb827973f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/steglatro-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Ertugliflozin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp120661",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ERTUGLIFLOZINE-L-PYROGLUTAMINEZUUR"
  ],
  "leaflet_url": null,
  "authorised_at": "2018/03/21",
  "procedure_number": "EMEA/H/C/004315",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/18/1267",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about ertugliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console